logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Class
    3. Antiarrhythmic

    Antiarrhythmic class drugs

    FiltersReset Filters
    30 results

    • akten

      (LIDOCAINE HYDROCHLORIDE ANHYDROUS)
      Thea Pharma Inc.
      Usage: AKTEN® is indicated for providing ocular surface anesthesia during ophthalmologic procedures.

    • amiodarone hydrochloride

      (Amiodarone Hydrochloride)
      Advagen Pharma Limited
      Usage: Amiodarone Hydrochloride Tablets are indicated for treating documented, life-threatening recurrent ventricular fibrillation and unstable tachycardia in adults who have not adequately responded to other antiarrhythmics or cannot tolerate alternative treatments.

    • amiodarone hydrochloride

      (Amiodarone Hydrochloride)
      Chartwell RX, LLC
      Usage: Amiodarone hydrochloride is indicated for treating documented life-threatening recurrent ventricular fibrillation and hemodynamically unstable tachycardia in adults unresponsive to other antiarrhythmics or when alternative medications are intolerable.

    • amiodarone hydrochloride

      (amiodarone hydrochloride)
      Zhejiang Poly Pharm. Co., Ltd.
      Usage: Amiodarone injection is indicated for the initiation of treatment and prevention of recurrent ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients unresponsive to other therapies. It can also be used for patients needing oral therapy but unable to take oral medication, facilitating a transition to oral amiodarone.

    • dofetilide 0.125mg

      (Dofetilide 0.125mg)
      Granules Pharmaceuticals Inc.
      Usage: Dofetilide is indicated for maintaining normal sinus rhythm in patients with atrial fibrillation/atrial flutter who have been converted from AF/AFl and for conversion of AF/AFl to normal sinus rhythm. It is reserved for symptomatic patients due to potential life-threatening ventricular arrhythmias.

    • flecainide acetate

      (flecainide acetate)
      Epic Pharma, LLC
      Usage: Flecainide Acetate Tablets are indicated for preventing paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. They are also used for documented life-threatening sustained ventricular tachycardia. Caution is advised due to proarrhythmic effects, and they should not be used post-myocardial infarction.

    • flecainide acetate

      (flecainide acetate)
      Bayshore Pharmaceuticals LLC
      Usage: Flecainide acetate tablets are indicated for preventing paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. They are also used for life-threatening documented ventricular arrhythmias, but should not be used post-myocardial infarction or for less severe arrhythmias. Consideration of risks is essential.

    • lidocaine

      (Lidocaine)
      AvKARE
      Usage: Lidocaine patch 5% is indicated for the relief of pain associated with post-herpetic neuralgia and should be applied only to intact skin.

    • lidocaine 5%

      (Lidocaine 5%)
      YARAL Pharma Inc.
      Usage: Lidocaine patch 5% is indicated for relieving pain associated with post-herpetic neuralgia and should be applied only to intact skin.

    • lidocaine 5% patch

      (Lidocaine 5%)
      Medcore LLC
      Usage: Lidocaine Patch 5% is indicated for the relief of pain associated with post-herpetic neuralgia. It should be applied exclusively to intact skin.